Search

Your search keyword '"Farzaneh-Far, Ramin"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Farzaneh-Far, Ramin" Remove constraint Author: "Farzaneh-Far, Ramin" Language english Remove constraint Language: english
133 results on '"Farzaneh-Far, Ramin"'

Search Results

1. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

8. Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis

12. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease

13. Thinking outside the box

16. Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post–Percutaneous Coronary Intervention (RIVER-PCI) trial

17. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.

18. Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.

22. Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.

23. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies.

24. Change in Leukocyte Telomere Length Predicts Mortality in Patients with Stable Coronary Heart Disease from the Heart and Soul Study.

25. Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy.

26. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.

28. Physical Fitness and Risk for Heart Failure and Coronary Artery Disease.

29. Physical Fitness and Telomere Length in Patients with Coronary Heart Disease: Findings from the Heart and Soul Study.

31. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul Study

32. A Functional Polymorphism in Renalase (Glu37Asp) Is Associated with Cardiac Hypertrophy, Dysfunction, and Ischemia: Data from the Heart and Soul Study.

33. Telomere Length Trajectory and Its Determinants in Persons with Coronary Artery Disease: Longitudinal Findings from the Heart and Soul Study.

34. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study

35. Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study

36. Development of an Echocardiographic Risk-Stratification Index to Predict Heart Failure in Patients With Stable Coronary Artery Disease: The Heart and Soul Study.

37. Cysteinyl-leukotrienes and the liver

45. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies

46. The spectrum of complement C9 staining in lupus nephritis.

50. Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.

Catalog

Books, media, physical & digital resources